EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Late-onset Quetiapine-related Tardive Dyskinesia Side Effects in a Patient with Psychotic Depression



Late-onset Quetiapine-related Tardive Dyskinesia Side Effects in a Patient with Psychotic Depression



Clinical Psychopharmacology and Neuroscience 12(2): 163-165



The atypical antipsychotics were believed to induce less extrapyramidal syndrome, including tardive dyskinesia (TD). Since the introduction of the quetiapine, it is also reported with less TD side effects. It even can relieve the symptoms of severe TD and reduce the risk of TD. The quetiapine's low affinity and fast dissociation from postsynaptic dopamine D2 receptors should give the least risk of producing the symptoms of TD. The quetiapine even can reduce the TD side effects related to clozapine, which has the lowest risk for TD. However, since the first case report of TD side effects related to quetiapine published on 1999, the safety of quetiapine in TD aspect has been questioned. Therefore, we want to share this case report, which was written to describe the severe late-onset TD side effects after long-term use of quetiapine in a patient with psychotic depression. The patient had no significant findings after concurrent comprehensive neurological examinations, magnetic resonance imaging of brain and electroencephalogram since the onset of TD.

(PDF emailed within 0-6 h: $19.90)

Accession: 054086051

Download citation: RISBibTeXText

PMID: 25191509

DOI: 10.9758/cpn.2014.12.2.163



Related references

Multi-segmental late onset idiopathic dystonia presenting as tardive dyskinesia and treated with quetiapine. European Neuropsychopharmacology 13(Supplement 4): S387-S388, September, 2003

Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to low-dose quetiapine. Movement Disorders 26(12): 2297-2298, 2012

Quetiapine-related tardive dyskinesia. American Journal of Psychiatry 158(10): 1737-1737, 2001

Tardive dyskinesia in a patient treated with quetiapine. World Journal of Biological Psychiatry 10(1): 54-57, 2009

Tardive dyskinesia related to quetiapine and confirmed by a DAT scan. Journal of Clinical Psychopharmacology 31(4): 535-538, 2012

Dyskinesia with fluoxetine: tardive or late-onset persistent, acute norfluoxetine dyskinesia?. Journal of Clinical Psychiatry 58(2): 85-86, 1997

The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression. Journal of Clinical Psychopharmacology 33(3): 391-397, 2013

Late onset involuntary movements in chronic schizophrenia: age-related vulnerability to "tardive" dyskinesia independent of extent of neuroleptic medication. Irish Medical Journal 78(9): 270-270, 1985

Quetiapine treatment of risperidone-related tardive dyskinesia. A case report. Actas Espanolas de Psiquiatria 31(5): 306-306, 2003

Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone. Clinical Neuropharmacology 26(6): 297-298, 2003

Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine. International Clinical Psychopharmacology 15(1): 57-60, 2000

Successful Management of Tardive Dyskinesia with Quetiapine and Clonazepam in a Patient of Schizophrenia with Type 2 Diabetes Mellitus. Clinical Psychopharmacology and Neuroscience 14(2): 218-220, 2016

Rapid remission of severe tardive dyskinesia and tardive dystonia with quetiapine. International Journal of Geriatric Psychiatry 20(3): 287-288, 2005

FDA advisers wary of expanding quetiapine use: clinicians air concerns about metabolic effects, tardive dyskinesia. American Journal of Health-System Pharmacy 66(10): 880, 882-880, 882, 2009

Early vs. late onset psychosis and tardive dyskinesia. Biological Psychiatry 21(13): 1291-1297, 1986